Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CYAN

Cyanotech (CYAN) Stock Price, News & Analysis

Cyanotech logo

About Cyanotech Stock (NASDAQ:CYAN)

Advanced Chart

Key Stats

Today's Range
$0.37
$0.46
50-Day Range
$2.83
$3.26
52-Week Range
$2.37
$6.29
Volume
3,680 shs
Average Volume
3,483 shs
Market Capitalization
$3.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CYAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cyanotech and its competitors with MarketBeat's FREE daily newsletter.

CYAN Stock News Headlines

Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
Q3 2025 Cyanotech Corp Earnings Call
See More Headlines

CYAN Stock Analysis - Frequently Asked Questions

Cyanotech Co. (NASDAQ:CYAN) posted its quarterly earnings data on Tuesday, November, 12th. The biotechnology company reported ($0.16) EPS for the quarter. The biotechnology company earned $5.85 million during the quarter. Cyanotech had a negative net margin of 19.50% and a negative trailing twelve-month return on equity of 44.71%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cyanotech investors own include AbbVie (ABBV), Gilead Sciences (GILD), Pfizer (PFE), Allena Pharmaceuticals (ALNA), Clarivate (CCC), Karyopharm Therapeutics (KPTI) and Madrigal Pharmaceuticals (MDGL).

Company Calendar

Last Earnings
11/12/2024
Today
7/12/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medicinals & botanicals
Sub-Industry
N/A
Current Symbol
NASDAQ:CYAN
CIK
768408
Employees
95
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.66)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$5.27 million
Net Margins
-19.50%
Pretax Margin
-19.48%
Return on Equity
-44.71%
Return on Assets
-19.12%

Debt

Debt-to-Equity Ratio
0.11
Current Ratio
1.06
Quick Ratio
0.28

Sales & Book Value

Annual Sales
$23.07 million
Price / Sales
0.14
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.33 per share
Price / Book
0.35

Miscellaneous

Outstanding Shares
7,160,000
Free Float
5,074,000
Market Cap
$3.29 million
Optionable
Not Optionable
Beta
-0.11
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:CYAN) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners